ClinicalTrials.govpublic full text
Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
pancreas cancer, metastatic pancreatic cancer, bortezomib, pd-1 antibody, chemotherapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811738
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.